Standardized Pill Imprint Codes: A Pharma Fantasy
Tóm tắt
To safely use medications, professionals and consumers need usable and reliable methods to identify tablets patients are prescribed and taking. Currently, each manufacturer assigns its own identifying codes and symbols. Standardization of the system for identifying solid dosage forms is a goal that has been widely advocated, yet stubbornly resistant to progress. Physicians, pharmacists, and consumers attempting to identify pills must use various methods which have shortcomings in ease of use, availability, and accuracy. Arguments have been advanced, particularly by pharmaceutical manufacturers, that evidence of unworkability of the current system is not compelling, and costs of retooling current manufacturing processes could be prohibitive. These issues are currently being explored by a task force led by the U.S. Pharmacopeia Safe Medication Use, and Pharmaceutical Forms Dosage Expert Committees. This paper presents a fictitious case study of an elderly patient succumbing to digoxin overdose illustrating the dilemmas posed in the tablet-imprint debate.
Tài liệu tham khảo
Chyka, P. A., and McCommon, S. W., Reporting of adverse drug reactions by poison control centres in the US. Drug Saf. 23(1):87–93, 2000.
Procedings United States Pharmacopeia Quinquennial Meeting 2000. United States Pharmacopeia Inc., Rockville MD, pp. 404–417, 2000.
Robertson, W. O., and Williams, D. H., Drug imprinting. 1984 update, JAMA 254(14):1964, 1985.
Robertson, W. O., Identifying tablets. Lancet 2(8357):1026, 1983.
Physicians' Desk Reference, 56th edn. Medical Economics Press, Montvale, NJ, 2002.
Drug Information for the Health Care Profession (USP-DI), 23 edn. Thompson Micromedix, Greewood Village, CO, 2003.
IDENT-A-DRUG, Pharmacists Letter, Therapeutic Research Center, Stockton, CA, 2002.
Vasudevan, P., Del Gianni, T., and Robertson, W. O., Avoiding medication mixups. Identifiable imprint codes. West J. Med. 165(6):352–354, 1996.
Bond, W. S., and Hussar, D. A., Detection methods and strategies for improving medication compliance. Am. J. Hosp. Pharm. 48(9):1978–1988, 1991.
Marder, S., Winkler, T., Tadaki, K., Bobbink, S., Robertson, and W. O., Decoding “drug imprints” at the millennium: A proposal to increase accuracy and reduce costs. Vet. Hum. Toxicol. 43(1):46–47, 2001.
Caravati, E. M., and McElwee, N. E., Use of clinical toxicology resources by emergency physicians and its impact on poison control centers. Ann. Emerg. Med. 20(2):147–150, 1991.
Winter, J. P., Hornfeldt, C. S., Weiland, M. J., and Ling, L. J., Analysis of initial requests for information of non-exposure related topics at a regional poison center. Vet. Hum. Toxicol. 30(2):108–109, 1988.
Kroner, B. A., Scott, R. B., Waring, E. R., and Zanga, J. R., Poisoning in the elderly: Characterization of exposures reported to a poison control center. J. Am. Geriatr. Soc. 41(8):842–846, 1993.
Blanc, P. D., Kearney, T. E., and Olson, K. R., Underreporting of fatal cases to a regional poison control center. West. J. Med. 162(6):505–509, 1995.
Drug packaging: Safety and convenience above all. Prescrire Int. 11(57):26–27, 2002.
Schwab, M., Oetzel, C., Morike, K., Jagle, C., Gleiter, C. H., and Eichelbaum, M., Using trade names: A risk factor for accidental drug overdose. Arch. Intern. Med. 162(9):1065–1066, 2002.
Palmer, M. E., Haller, C., McKinney, P. E., Klein-Schwartz, W., Tschirgi, A., Smolinske, S. C., Woolf, A., Sprague, B. M., Ko, R., Reveon, G., Nelson, L. S., Dodd-Butera, T., Bartlett, W. D., and Landzberg, B. R. Adverse events associated with dietary supplements: An observational study. Lancet 361(9352):101–106, 2003.